Fisher & Paykel Healthcare Corp Ltd, a leading health care equipment and supply company, has been a steady performer in the market, with its share price holding relatively firm in recent days. Trading at a slight discount to its net asset value, the company’s stability is a testament to its solid foundation and commitment to innovation.
At the heart of Fisher & Paykel’s success lies its focus on designing and manufacturing cutting-edge heated humidification products and systems for respiratory care and sleep apnea treatment. As the global demand for respiratory care devices continues to rise, the company is poised to reap the benefits of this growing trend.
Market research paints a compelling picture of the respiratory care devices market, with a projected growth rate of 7.3% from 2025 to 2030. This significant expansion is driven by several key factors, including:
- An increasing geriatric population, which requires more respiratory care devices
- Rising prevalence of chronic diseases, such as chronic obstructive pulmonary disease (COPD) and asthma
- Growing awareness of the importance of respiratory care and sleep apnea treatment
As the global respiratory care devices market continues to grow, Fisher & Paykel is well-positioned to capitalize on this trend. With its expertise in heated humidification products and systems, the company is poised to deliver strong performance in the coming years.